Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis

Patients with cancer have an increased risk of both venous thromboembolism (VTE) requiring anticoagulation and thrombocytopenia. The optimal management is unclear. We performed a systematic review and meta-analysis to evaluate the outcomes in these patients. We searched MEDLINE, Embase, Scopus, and...

Full description

Saved in:
Bibliographic Details
Published in:Thrombosis research 2023-07, Vol.227, p.8-16
Main Authors: Wang, Tzu-Fei, Carrier, Marc, Carney, Brian J., Kimpton, Miriam, Delluc, Aurélien
Format: Article
Language:English
Subjects:
Adult
Anticoagulants - adverse effects
Anticoagulation
cancer-associated thrombosis
Hemorrhage - chemically induced
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Malignancy
meta-analysis
Neoplasm Recurrence, Local - chemically induced
Neoplasm Recurrence, Local - complications
Systematic review
Thrombocytopenia
Thrombocytopenia - chemically induced
Thrombocytopenia - complications
Thrombocytopenia - drug therapy
Thrombosis - chemically induced
Thrombosis - etiology
Venous Thromboembolism - chemically induced
Venous Thromboembolism - etiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with cancer have an increased risk of both venous thromboembolism (VTE) requiring anticoagulation and thrombocytopenia. The optimal management is unclear. We performed a systematic review and meta-analysis to evaluate the outcomes in these patients. We searched MEDLINE, Embase, Scopus, and Cochrane Central Register of Controlled Trials from inception to February 5, 2022. Studies assessing adult patients with cancer-associated thrombosis and platelet count
ISSN:0049-3848
1879-2472
DOI:10.1016/j.thromres.2023.05.012